Related Experiment Video
Updated: Aug 14, 2026
Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
Published on: February 17, 2011
BRCA1 carries tumor suppressor activity distinct from that of p53 and p21
V Randrianarison1, D Marot, N Foray
1Laboratoire de Vectorologie et Transfert de gènes, CNRS UMR 1582, Institut Gustave Roussy, 94805 Villejuif Cedex, France.
Abstract:
The loss of BRCA1 function appears as an essential step in breast and ovarian epithelial cells oncogenesis and is consistent with the concept that BRCA1 acts as a tumor suppressor gene. However, the mechanism underlying this activity is not understood. In 1996, a retroviral vector was used for BRCA1 delivery to demonstrate that the transfer of BRCA1 inhibits breast and ovarian cancer cell growth. Since this early observation, the tumor growth inhibitory activity of BRCA1 in vivo has not been further documented. Here we re-address this issue and report experiments designed to evaluate the potential of adenovirus-mediated BRCA1 delivery to suppress the growth of cells with various status of endogenous BRCA1 in comparison with p53 and p21. Delivery of wild-type BRCA1 by an adenovirus vector in breast and ovarian tumor cells, decreases in vitro proliferation and tumorigenicity. Similarly, in vivo administration of BRCA1 provokes tumor growth retardation or regression comparable to that obtained with p53 or p21. The antitumor effect of BRCA1 is not observed upon transfer of a mutant lacking the 542 C-terminal residues. The p53- or p21-mediated antiproliferative activities are likely to bear on their capacity to induce apoptosis and/or interfere with cell cycle checkpoint. By contrast, the data presented here show that neither of these mechanisms can account for the BRCA1-mediated antitumor activity and suggest the activation of an alternative route.
Insights
BRCA1 delivery using adenovirus vectors suppresses breast and ovarian cancer cell growth. This tumor suppressor gene
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- BRCA1 is a tumor suppressor gene crucial for preventing breast and ovarian cancers.
- The exact mechanisms of BRCA1's tumor suppressor activity remain unclear.
- Previous studies showed BRCA1 transfer inhibits cancer cell growth, but in vivo data is limited.
Purpose of the Study:
- To investigate the efficacy of adenovirus-mediated BRCA1 delivery in suppressing tumor growth.
- To compare BRCA1's antitumor effects with those of p53 and p21.
- To elucidate the mechanism behind BRCA1's tumor suppressor activity.
Main Methods:
- Adenovirus vectors were used to deliver wild-type and mutant BRCA1 to breast and ovarian cancer cells.
- In vitro proliferation and tumorigenicity assays were performed.
- In vivo tumor growth was monitored after BRCA1 administration.
- Experiments compared BRCA1's effects with p53 and p21 delivery.
Main Results:
- Adenovirus-mediated BRCA1 delivery significantly decreased in vitro proliferation and tumorigenicity of cancer cells.
- In vivo administration of BRCA1 resulted in tumor growth retardation or regression, comparable to p53 and p21.
- A BRCA1 mutant lacking C-terminal residues did not exhibit antitumor effects.
- BRCA1's antitumor activity does not appear to rely on apoptosis or cell cycle checkpoint interference.
Conclusions:
- Adenovirus-mediated BRCA1 delivery is a viable strategy for suppressing breast and ovarian tumor growth.
- BRCA1 functions as a tumor suppressor through a mechanism distinct from p53 and p21.
- Further research is needed to identify the alternative pathway mediating BRCA1's antitumor effects.
Related Concept Videos
02:23Abnormal Proliferation
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...